1271223

Janssen Pharmaceuticals, Inc — FEI 2242843

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 14, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Titusville, NJ (United States)